PRINCETON, N.J., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) and Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Joseph A. Mollica, Interim President and Chief Executive Officer of Pharmacopeia, and John L. Higgins, President and Chief Executive Officer of Ligand, will deliver a presentation at the Rodman & Renshaw 10th Annual Healthcare Conference. Recently, Ligand and Pharmacopeia entered into a definitive merger agreement, under which Ligand will acquire Pharmacopeia.
